Expectedly, major NLRP3 inflammasome markers IL-1β and IL-18 were elevated in the sera of WD patients, suggesting an essential role for inflammasome dysregulation in the development of neuroinflammation in WD. The gene discussed is IL1B; the disease is Wilson disease.